ASH: Sustained Benefit Seen for Etranacogene Dezaparvovec in Hemophilia B

WEDNESDAY, Dec. 10, 2025 (HealthDay News) -- For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in s